RNA sequencing of the early recovery stage of COVID-19 showed that classical CD14++ and CD14++ IL-1β+;monocytes are of greater abundance with high expression of inflammatory genes, indicating that IL-1β may be a potential target for the COVID-19 intervention (105). The gene discussed is CD14; the disease is COVID-19.